Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences

Sacubitril/valsartan reduces mortality in heart failure with reduced ejection fraction (HFrEF) patients, partially due to cardiac reverse remodeling (RR). Little is known about the RR rate in long-lasting HFrEF and the evolution of advanced echocardiographic parameters, despite their known prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Castrichini, Matteo, Manca, Paolo, Nuzzi, Vincenzo, Barbati, Giulia, De Luca, Antonio, Korcova, Renata, Stolfo, Davide, Di Lenarda, Andrea, Merlo, Marco, Sinagra, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230879/
https://www.ncbi.nlm.nih.gov/pubmed/32218231
http://dx.doi.org/10.3390/jcm9040906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230879/
https://www.ncbi.nlm.nih.gov/pubmed/32218231
http://dx.doi.org/10.3390/jcm9040906

Ejemplares similares